Joanna J. Wykrzykowska

Showing 1-20 of 56 articles

Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry

Modolo R, Chang C-C, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, Roos M, Wolff Q, Wykrzykowska J.J, de Winter R.J, Piazza N, Richardt G, Abdel-Wahab M, Soliman O, Onuma Y, Van Mieghem N, Serruys PW

May 23, 2019 | 10.4244/EIJ-D-19-00362

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen R, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter R.J, Tijssen J, Henriques J, Wykrzykowska J.J, Ijsselmuiden A, Kauer F, Beijk M, Vis M, Koch K

May 23, 2019 | 10.4244/EIJ-D-19-00325

Coronary interventions

How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials

Katagiri Y, Serruys PW, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J.J, Piek J, Onuma Y

May 20, 2019 | 10.4244/EIJ-D-18-00607

Coronary interventions

Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J.J, Wijns W, de Winter R.J, Buszman P, Onuma Y, Serruys PW

May 7, 2019 | 10.4244/EIJ-D-18-01201

Coronary interventions

Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score

Kraak R, Tijssen RY, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Thijssen J, Piek J, de Winter R.J, Henriques J, Wykrzykowska J.J

May 7, 2019 | 10.4244/EIJ-D-18-00884

Coronary interventions

Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent.

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J.J, Asano T, Kogame N, Takahashi K, Chang C-C, de Winter R.J, Serruys PW, Wijns W

February 5, 2019 | 10.4244/EIJ-D-18-00944

Coronary interventions

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with three-vessel disease:2-year follow-up of the SYNTAX II study

Serruys PW, Kogame N, Katagiri Y, Modolo R, Buszman P, Iniguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Piek J, Wykrzykowska J.J, Escaned J, Banning A, Farooq V, Onuma Y

January 15, 2019 | 10.4244/EIJ-D-18-00980

Coronary interventions

A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial

Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C-C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J.J, Piek J, Serruys PW, Onuma Y, Chen Y

December 20, 2018 | 10.4244/EIJ-D-18-00461

Coronary interventions

Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study

van Zandvoort L, Dudek D, Weber-Albers J, Abizaid A, Christiansen EH, Muller D, Kochman J, Kołtowski Ł, Lassen JF, Wojdyla R, Wykrzykowska J.J, Onuma Y, Daemen J

December 7, 2018 | 10.4244/EIJ-D-18-00491

Coronary interventions

How does the failure of Absorb apply to the other bioresorbable scaffolds?: Expert review of first-in-man and pivotal trials.

Katagiri Y, Serruys PW, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J.J, Piek J, Onuma Y

November 6, 2018 | 10.4244/EIJ-D-18-00607

Coronary interventions

Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)

Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J.J, Abizaid A, Ormiston J, Chevalier B, Serruys PW

October 12, 2018 | 10.4244/EIJ-D-18-00301

STEMI

Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial

Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R.J, Wykrzykowska J.J, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys PW

August 24, 2018 | 10.4244/EIJ-D-17-00884

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iniguez A, Janssens L, Smits P, Wykrzykowska J.J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys PW

August 3, 2018 | 10.4244/EIJ-D-17-00461

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Tijssen RY, Kraak R, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Elias J, van Dongen I, Koch K, Baan Jr J, Vis M, de Winter R.J, Piek J, Tijssen J, Henriques J, Wykrzykowska J.J

July 20, 2018 | 10.4244/EIJ-D-18-00335

Coronary interventions

Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial

Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R.J, Tijssen J, Onuma Y, Serruys PW, Wykrzykowska J.J

July 20, 2018 | 10.4244/EIJ-D-17-01152

Coronary interventions

Acute and Long-term Relocation of Minimal Lumen Area after Bioresorbable Scaffold or Metallic Stent Implantation.

Katagiri Y, Serruys PW, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J.J, Chevalier B, Mintz G, Stone G.W., Onuma Y

July 4, 2018 | 10.4244/EIJ-D-18-00422

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iniguez A, Janssens L, Smits P, Wykrzykowska J.J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys PW, Sabaté M

April 20, 2018 | 10.4244/EIJ-D-17-00462

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska J.J, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys PW, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Coronary interventions

Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?

Sotomi Y, Onuma Y, Miyazaki Y, Asano T, Katagiri Y, Tenekecioglu E, Jonker H, Dijkstra J, de Winter R.J, Wykrzykowska J.J, Stone G.W., Popma J.J, Kozuma K, Tanabe K, Serruys PW, Kimura T

August 4, 2017 | 10.4244/EIJ-D-17-00070

Coronary interventions

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J.J, de Winter R.J, Windecker S, Onuma Y, Serruys PW, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Latest news

Late breaking trials

Hot off the press: access today’s Late Breaking Trials - EuroPCR 2019

May 21, 2019

New issue

EuroPCR 2019 issue: Basilica, new BRS generation, EBC Consensus and much more! Available now!

(Cover Image: 3 requirements for optimal traversal system positioning)

May 20, 2019

JAA

"Shocktopics" and Coronary IVL in the JAA of the week

May 21, 2019

Guidance papers

Guidelines, consensus & position papers

April 9, 2019

Guidance papers

14th Consensus from the European Bifurcation Club

May 20, 2019

Editorial

The art of educating a fellow: a “mother-and-child” relationship

May 20, 2019

EAPCI column

The year ahead: EAPCI milestones by Andreas Baumbach

May 20, 2019

Joanna J. Wykrzykowska

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke